NOVO NORDISK WORLDWIDE HEALTH CARE GROUP SALES UP 16% TO $1.21 BIL. IN 1993
Executive Summary
Novo Nordisk's health care group worldwide sales totaled $1.21 bil. (based on an exchange rate of $1 = DKK 6.7725) in 1993, an increase of 16% over 1992, the Danish company reported March 9. Within the health care group, biopharmaceutical division sales jumped 34%, "primarily due to strongly increasing sales of human growth hormone, especially in the Japanese market," Novo said.